Literature DB >> 14175

Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.

K H Jakobs, W Saur, G Schultz.   

Abstract

The effects of the alpha- and beta-adrenergic components of epinephrine on adenylate cyclase activity were studied in lyastes of human platelets. The beta-adrenergic component increased enzyme activity between 20 and 50%, whereas the alpha-adrenergic component caused a concentration-dependent reduction of adenylate cyclase activity. The maximal inhibition of adenylate cyclase was 50 to 60% with about 100 muM epinephrine; about 1 muM epinephrine caused half-maximal inhibition. The alpha-adrenergic reduction of adenylate cyclase activity appeared to be immediate and was specific for platelets from species in which alpha-adrenergic stimulation caused aggregation. Adenylate cyclase activity measured in the presence of prostaglandins of fluoride was also reduced by the alpha-adrenergic component of epinephrine, but the inhibitory effect was less than on basal activity. In contrast, the 5'-guanylylimidodiphosphate-stimulated enzyme was not affected by stimulation of alpha-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 14175

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  62 in total

1.  Serial changes in the myocardial beta-adrenergic signalling system in two models of non-insulin dependent diabetes mellitus.

Authors:  B Huisamen; E Marais; S Genade; A Lochner
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

Authors:  C Hoffmann; M R Leitz; S Oberdorf-Maass; M J Lohse; K-N Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-17       Impact factor: 3.000

3.  Distinct pathways for beta-adrenoceptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein alpha-subunits in chicken cardiomyocytes.

Authors:  C Reithmann; B Panzner; K Werdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

4.  Binding of [3H]-dihydroergocryptine to alpha-adrenoceptors on intact human platelets [proceedings].

Authors:  D J Boullin; J M Elliott
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

5.  Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.

Authors:  F Niroomand; R A Mura; L Piacentini; W Kübler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

6.  Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence.

Authors:  J A García-Sevilla; I Ulibarri; L Ugedo; M Gutierrez
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Acute change in the cyclic AMP content of rat mammary acini in vitro. Influence of physiological and pharmacological agents.

Authors:  R A Clegg; I Mullaney
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

8.  Acceleration of the adipocyte adenylate cyclase turn-off reaction by inhibitory hormonal factors.

Authors:  K H Jakobs; K Aktories; G Shultz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Prostaglandin-stimulated GTP hydrolysis associated with activation of adenylate cyclase in human platelet membranes.

Authors:  H A Lester; M L Steer; A Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling.

Authors:  Susanne Lutz; Roman A Mura; Hans Joerg Hippe; Christiane Tiefenbacher; Feraydoon Niroomand
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.